Business / Finance

RSS

Aerocrine net sales increase 10% to SEK 93.5m for January - December 2011

Aerocrine: January - December 2011. Global Net sales grew by 10% to SEK 93.5m (84.7). Adjusted for currency fluctuations, net sales rose by 18%.

24 Feb 2012

Sandvik reaches agreement with Orchid to sell medical solutions unit

Sandvik has reached an agreement with Orchid Orthopedic Solutions (Orchid), owned by Altor Fund III, to divest Sandvik Medical Solutions, a unit within the Sandvik Venture business area with contract manufacturing of medical implants and instruments for orthopaedic and dental applications.

24 Feb 2012

ValueOptions, LifeWIRE partner to create mobile monitoring, intervention and counseling program

ValueOptions, the nation's largest independent behavioral health and wellness company, and LifeWIRE announced today a joint teaming agreement to create a mobile monitoring, intervention and counseling program.

23 Feb 2012

Medivir reports net sales of SEK 698.6M for fiscal 2011

Today, Medivir AB, a research-based specialty pharmaceutical company focused on infectious diseases, is publishing its Interim Report for the period 1 January - 31 December and its operational report for the fourth quarter of 2011.

23 Feb 2012

ANFP renames and re-launches its charitable foundation

As a part of its recently announced strategic rebranding initiative, the Association of Nutrition & Foodservice Professionals (ANFP) has renamed and re-launched its charitable foundation.

23 Feb 2012

Roche grants in vitro diagnostics product license for real-time PCR technology to LTC

Roche and Life Technologies Corporation announced today that they have entered into two license agreements to allow LTC to expand its PCR offerings for diagnostics applications.

23 Feb 2012

Healthcare Realty Trust reports total revenues of $76.4M for fourth quarter 2011

Healthcare Realty Trust Incorporated today announced results for the fourth quarter ended December 31, 2011. Normalized FFO for the three months ended December 31, 2011 totaled $0.33 per diluted common share.

23 Feb 2012

Onyx reports total operating revenue of $237.0M for fourth quarter 2011

Onyx Pharmaceuticals, Inc. today reported its financial results for the full year and fourth quarter 2011. Onyx reported non-GAAP net income of $42.0 million, or $0.66 per diluted share, for the full year 2011 compared to non-GAAP net income of $39.2 million, or $0.63 per diluted share, for the same period in 2010.

23 Feb 2012

Express Scripts fourth quarter gross profit increases 8% to $0.9 billion

Express Scripts, Inc. announced 2011 fourth quarter and full year net income from continuing operations of $290.4 million and $1,275.8 million, or $0.59 and $2.53 per diluted share, respectively.

23 Feb 2012

Volcano fourth quarter revenues increase 14% to $92.7 million

Volcano Corporation, a leading developer and manufacturer of precision guided therapy tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, today said revenues in the fourth quarter of 2011 increased 14 percent versus the fourth quarter of 2010.

23 Feb 2012

MannKind net loss for 2011 decreases to $160.8 million

MannKind Corporation today reported financial results for the fourth quarter and year ended December 31, 2011.

23 Feb 2012

Dyax fourth quarter total revenues decrease to $8.5 million

Dyax Corp. today announced financial results for the fourth quarter and year ended December 31, 2011.

22 Feb 2012

CardioNet fourth quarter revenue decreases 6.6% to $26.8 million

CardioNet, Inc., a leading wireless medical technology company with a current focus on the diagnosis and monitoring of cardiac arrhythmias, today reported results for the fourth quarter and full year-ended December 31, 2011.

22 Feb 2012

Questcor fourth quarter net sales increase to $75.5 million

Questcor Pharmaceuticals, Inc. today reported financial results for the fourth quarter and full year ended December 31, 2011.

22 Feb 2012

Publicis Groupe acquires UBS

Publicis Groupe announced today that it has acquired U-Link Business Solutions Co. Ltd (UBS), one of the leading Chinese agencies specialized in healthcare communications.

22 Feb 2012

Mylan receives $300M committed financing

Mylan Inc. today announced that it has entered into a facility agreement with a syndicate of banks to securitize up to $300 million of U.S. accounts receivable. The facility is committed and has a maturity of three years. The interest rate on any outstanding borrowings will be more than 100 basis points lower than the rate on the company's secured credit facilities.

21 Feb 2012

GTx fourth quarter net loss increases to $10.7 million

GTx, Inc. today provided a Company update and reported financial results for the fourth quarter and full year 2011.

21 Feb 2012

Medco fourth-quarter total net revenues increase 12.2% to record $19.0 billion

Medco Health Solutions, Inc. today reported record fourth-quarter 2011 GAAP diluted EPS of $1.08, an increase of 22.7 percent, which includes expenses associated with the pending merger with Express Scripts, Inc. of $43.6 million before provision for income taxes. When excluding these merger-related expenses, diluted EPS increased 29.5 percent over fourth-quarter 2010.

21 Feb 2012

Cadila Pharmaceuticals to distribute Bactiguard products throughout India

Bactiguard has signed an exclusive co-operation with Cadila Pharmaceuticals, one of the largest healthcare manufacturing groups in India. A signing process will take place at the Swedish Ambassador's residency tonight.

21 Feb 2012

Flaws in ESI-Medco efficiency claims over proposed merger

David A. Balto, an antitrust attorney in Washington and former Policy Director of the Federal Trade Commission, released a white paper today exposing the flaws in efficiency claims made by Express Scripts, Inc. and Medco Health Solutions, Inc. with respect to their proposed merger.

20 Feb 2012